Meningitis B Vaccine Edinburgh | Bexsero Private Vaccination

Meningitis B is the most common cause of bacterial meningitis in the UK. The disease can progress from the first symptoms to life-threatening illness within 24 hours, and even when treated promptly, it can leave lasting complications including hearing loss, limb amputation and brain injury. Bexsero, the meningitis B vaccine, provides protection against the group B strain — the one responsible for the majority of meningococcal cases in this country. At Edinburgh Vaccination Clinic (Bruntsfield Pharmacy), we offer private Bexsero vaccination for adults, university students, and anyone not covered by the NHS schedule.

This guide explains who needs the meningitis B vaccine, how many doses are required, who is at the highest risk, and how to book in Edinburgh. For the full range of adult vaccines we provide, see our speciality vaccines page.

What is meningitis B and why does it matter?

Bacterial meningitis is an infection of the membranes that surround the brain and spinal cord. Meningococcal group B (MenB) bacteria are responsible for around 60% of all meningococcal disease cases in the UK. Unlike some other forms of bacterial meningitis, MenB has no age ceiling — it affects babies, children, teenagers and young adults, with university students representing a particularly high-risk group.

The disease can be devastating. In the most serious cases, it causes septicaemia (blood poisoning) as well as meningitis, leading to organ failure, gangrene and death. Around one in ten people who develop meningococcal disease do not survive, and of those who do, one in four is left with permanent after-effects — including deafness, brain injury, and limb loss following amputation.

Speed of diagnosis and treatment is critical, but the safest approach is prevention. Bexsero, the meningitis B vaccine, is the most effective tool currently available to protect against MenB disease.

Who needs the meningitis B vaccine?

The NHS meningitis B programme covers babies, who receive Bexsero at 8 weeks, 16 weeks, and 1 year. Beyond that, the NHS does not routinely fund MenB vaccination for older children, teenagers or adults — even though the risk does not disappear after infancy. This means the vast majority of people over the age of two have no MenB protection unless they seek it privately.

The groups who stand to benefit most from private Bexsero vaccination include:

Why isn’t the meningitis B vaccine available on the NHS for adults?

When the Joint Committee on Vaccination and Immunisation (JCVI) recommended Bexsero for the NHS infant programme in 2014, the decision was based on cost-effectiveness modelling that prioritised the age group with the highest incidence of disease: babies under one year. The programme was not extended to older children or adults, not because the vaccine does not work in those groups — it does — but because the cost-per-case-prevented calculation at a population level did not meet the threshold for routine NHS funding beyond infancy.

That gap leaves a large portion of the population — including the second highest-risk group, university students — without access through the NHS. Private vaccination is currently the only route for most adults and older teenagers who want protection. Suitability, dose schedule and any clinical considerations are confirmed at the consultation with one of our Independent Prescriber pharmacists.

Meningitis B and university students: why the risk spikes at freshers

University students are at significantly higher risk of meningococcal disease than the general adult population. The reasons are well documented and relate to the specific social and living conditions of student life: large numbers of people from different parts of the country mixing for the first time, sharing accommodation, spending time in crowded indoor spaces, and often experiencing sleep deprivation and changes in routine that can affect immune resilience.

Meningococcal bacteria are carried harmlessly in the throat by a proportion of people at any one time. Carriage rates are significantly higher among students than in the general population — estimated at around 25% compared with roughly 10% in adults overall. Most carriers never develop disease, but they can transmit the bacteria to others whose immune systems do not manage the infection as effectively.

The risk is concentrated in the first few weeks at university, which is why timing matters. To have full protection in place before freshers week, students need to book early enough to complete both doses of Bexsero, with the second dose given at least one month after the first.

It is also worth noting that while the NHS does offer the MenACWY vaccine to students going to university for the first time (via their GP), MenACWY does not cover the group B strain, which is responsible for the majority of cases. Bexsero, which covers group B, must be obtained privately.

About Bexsero — the meningitis B vaccine

Bexsero is a meningococcal group B (MenB) vaccine manufactured by GSK. It was licensed in Europe in 2013 and introduced into the UK infant immunisation schedule in 2015 — the first country in the world to offer a national MenB vaccination programme for babies. Clinical trials and post-marketing surveillance have confirmed its effectiveness in reducing invasive MenB disease.

Bexsero contains four components derived from the outer surface of meningococcal group B bacteria. It does not contain live bacteria and cannot cause meningococcal disease. Common side effects include soreness at the injection site, fatigue, headache and temporary muscle aches, typically resolving within a day or two.

Bexsero is not a combined vaccine — it protects only against group B meningococcal bacteria. It does not replace the MenACWY vaccine (which covers groups A, C, W and Y) and the two vaccines address different but complementary risks. Our pharmacists will review which combination is relevant for you at the consultation.

How many doses of the meningitis B vaccine do adults need?

Adults and older teenagers (aged 11 and above) who have not previously been vaccinated against MenB need two doses of Bexsero. The doses are given at least one month apart. There is no requirement to have both doses at the same clinic, but many people find it more convenient to book both here at Edinburgh Vaccination Clinic.

For people who received part of the infant schedule as babies (before 2015) but did not complete it, the appropriate course is confirmed at consultation, taking into account what was received and when. Adults who received the vaccine as infants may have waning immunity and benefit from a booster dose in certain higher-risk situations; this is assessed individually.

Meningitis B vaccine for adults with medical conditions

Certain medical conditions significantly increase the risk of invasive meningococcal disease, making vaccination not just advisable but important. The NHS does recognise these groups as higher priority and in some cases the vaccine may be available on the NHS, but private provision is often the more straightforward and faster route.

Conditions that elevate meningococcal risk include absence or dysfunction of the spleen (asplenia or hyposplenism), complement system deficiencies (including those taking eculizumab or other complement inhibitor medications), and certain immunocompromising conditions. If you have one of these conditions and have not been vaccinated, this is reviewed at consultation alongside the appropriate scheduling of both MenB and MenACWY vaccines.

How much does the meningitis B vaccine cost in Edinburgh?

Current pricing for Bexsero is published on our vaccine prices page. As a two-dose course, the full cost of protection covers both appointments. Each appointment price includes the clinical consultation with one of our Independent Prescriber pharmacists, the suitability check, vaccine administration and aftercare advice — there are no separate consultation fees added on top.

We understand the cost is a consideration. The context worth keeping in mind is that meningococcal disease, when it occurs, can require intensive hospital treatment, extended rehabilitation, and in some cases causes permanent disability or death. For families and individuals making the decision, private Bexsero vaccination represents a defined, upfront cost against a disease whose consequences are unpredictable and can be catastrophic.

Why choose Edinburgh Vaccination Clinic for your meningitis B vaccine?

We are an award-winning private vaccination clinic based at 129 Bruntsfield Place in Edinburgh, with Independent Prescriber pharmacists on site who carry out every consultation personally. This means that questions about dose schedule, suitability, timing, and interaction with other vaccines are answered by a qualified prescriber — not a receptionist following a script.

Book your meningitis B vaccine appointment online

Use the secure booking widget below to choose an appointment time that suits you. Your appointment includes a clinical consultation with one of our Independent Prescriber pharmacists, who will confirm suitability, explain the dose schedule, administer the vaccine and provide aftercare advice.

Meningitis B vaccine Edinburgh — your questions answered

Can I get the meningitis B vaccine on the NHS as an adult?

The NHS meningitis B (Bexsero) programme covers babies at 8 weeks, 16 weeks, and 1 year. It is not routinely available on the NHS for older children, teenagers or adults. The exceptions are certain high-risk medical groups including those with asplenia or complement deficiencies, where NHS access may be possible via a GP or specialist referral. For most adults and university students, private vaccination is the only route.

How many doses of Bexsero do adults need?

Adults and older teenagers who have not previously been vaccinated against MenB need two doses of Bexsero, given at least one month apart. The dose schedule and any individual clinical considerations are confirmed at your consultation with one of our Independent Prescriber pharmacists.

Is the meningitis B vaccine the same as MenACWY?

No. These are different vaccines covering different strains of meningococcal bacteria. Bexsero (MenB) protects against group B, which causes the majority of meningococcal disease in the UK. MenACWY covers groups A, C, W and Y. The NHS offers MenACWY to teenagers and first-time university students, but does not routinely offer MenB beyond infancy. Both vaccines can be given; the appropriate combination is reviewed at consultation.

When should university students get the meningitis B vaccine?

Students should aim to have dose 1 in July or early August, so that dose 2 (given at least one month later) can be completed before freshers week in September. The risk of meningococcal disease is concentrated in the first weeks of term, when large numbers of students from different regions mix together for the first time. Leaving it until you arrive at university may not give you time to complete both doses before the highest-risk period.

What are the side effects of Bexsero?

Common side effects include soreness, redness or swelling at the injection site, fatigue, headache and temporary muscle aches. These typically resolve within one to two days. Serious reactions are rare. Full aftercare information and what to watch for is provided at your appointment.

How much does the meningitis B vaccine cost privately in Edinburgh?

Current pricing per dose is published on our vaccine prices page. As adults require two doses, the full course cost covers two appointments. Each appointment includes the clinical consultation, suitability check, vaccine administration and aftercare — no separate consultation fee is added.

Do I need a GP referral to get the meningitis B vaccine privately?

No. You can book directly online without a GP referral. Our Independent Prescriber pharmacists carry out the suitability assessment at the appointment. If you have a complex medical history or are taking certain medications, it may be helpful to bring a list of your current medicines to the appointment.

Can Bexsero be given at the same time as other vaccines?

In many cases yes, but co-administration with other vaccines depends on which vaccines are involved and the clinical situation. Our pharmacists review co-administration suitability at the consultation and advise on the best scheduling approach where multiple vaccines are needed.

Last reviewed: 21 June 2026